CJC no-DAC + Ipamorelin 5mg/5mg
$140.00
- Free US shipping over $150
- HPLC-tested at 99%+ purity
- US-based fulfillment
Used in Muscle Growth Protocol.
Overview
Description
A gentle growth hormone–supporting peptide researched for recovery, improved sleep quality, and lean body composition without overstimulation. Often chosen for longevity, muscle preservation, and lifestyle-friendly wellness support.
Ipamorelin is favored for its clean profile in research, as it is commonly associated with minimal appetite and stress-hormone effects, making it a popular option for consistent, long-term protocols.
Scientific Overview
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue (GHRP). It has been studied for stimulating endogenous growth hormone release via ghrelin receptor signaling while demonstrating minimal impact on cortisol and prolactin in research settings. Research interest includes recovery pathways, metabolic efficiency, and tissue-repair signaling.
Product Details
- Compound: Ipamorelin
- Vial Size: 5mg
- Purity: ≥99%
- Form: Lyophilized powder
This product is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use by the FDA or any other regulatory agency. Store in a cool, dry environment prior to reconstitution and handle using appropriate laboratory and aseptic techniques.
Frequently asked questions
Yes. Every batch of CJC no-DAC + Ipamorelin 5mg/5mg undergoes independent third-party testing using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). The Certificate of Analysis is published and accessible from the product page.
CJC no-DAC + Ipamorelin 5mg/5mg sold by MHS Longevity is verified to 99%+ purity, with the result documented in each batch's Certificate of Analysis. Anything below that threshold is rejected before release.
The Certificate of Analysis for CJC no-DAC + Ipamorelin 5mg/5mg is available directly from the product page and on our Third-Party Test Results page. Each COA includes the batch identifier, test date, testing method, and verified purity percentage.
CJC no-DAC + Ipamorelin 5mg/5mg ships from our US-based facility with standard or expedited options. Orders over $150 qualify for free standard US shipping. All orders are packaged discreetly with documented handling protocols.
No. CJC no-DAC + Ipamorelin 5mg/5mg is supplied strictly for laboratory research purposes only. It is not approved by the FDA for human or veterinary use, and it is not intended to diagnose, treat, cure, or prevent any disease.
MHS Longevity is a veteran-owned operation focused on pharmaceutical-grade research compounds. We source from vetted manufacturers, batch-test independently with HPLC and Mass Spectrometry, and publish every Certificate of Analysis. Pricing is transparent and the testing process is documented end-to-end.
Convenience and pre-validated ratio. The 1:1 mass ratio is what most of the published GH-axis co-administration research uses, and the combined vial removes the per-experiment manual-mixing step. Research designs that need a different ratio — or that need to vary the ratio across experimental arms — should source CJC-1295 No-DAC and Ipamorelin separately as single-molecule products.
Yes — and this is explicitly verified on the Certificate of Analysis. The With-DAC version of CJC-1295 carries a maleimidopropionyl modification that the No-DAC version lacks. Mass spectrometry confirms the absence of that modification for every batch released as 'No-DAC.' Researchers requiring the With-DAC version should not use this combined product, since the two CJC-1295 forms have substantially different half-life profiles.
CJC-1295 No-DAC engages the GHRH receptor; Ipamorelin engages the ghrelin / growth-hormone-secretagogue receptor. Single-component administration of either characterizes one pathway in isolation. The combined formulation characterizes the response when both pathways are engaged simultaneously, which the published research consistently reports as producing larger GH-release endpoints than either component alone — though the exact synergy profile is research-design dependent and should be evaluated against the primary literature.
The combined formulation is sent to an independent third-party laboratory for HPLC and Mass Spectrometry analysis of each component plus ratio and form confirmation before each batch is released. The lab's identifier, test date, per-component verification, ratio result, and No-DAC form confirmation are published on the Certificate of Analysis for that batch.
You may also like
Research & buying
The evidence behind CJC no-DAC + Ipamorelin 5mg/5mg and the questions to ask any vendor before you order.
Research details — CJC no-DAC + Ipamorelin 5mg/5mg
The CJC No-DAC + Ipamorelin combination packages two complementary growth-hormone-axis research peptides into a single pre-validated formulation: 5mg of CJC-1295 No-DAC (a Modified GRF(1-29) GHRH-receptor agonist) and 5mg of Ipamorelin (a selective ghrelin / growth-hormone-secretagogue receptor agonist). The two peptides engage complementary pathways within the growth-hormone axis, and co-administration is one of the most commonly used research-protocol designs in the GH-axis literature. This guide explains what the combined product is, the research-protocol logic for the pairing, and how the dual-peptide formulation is independently verified.
What is CJC No-DAC + Ipamorelin?
The product combines two well-characterized synthetic peptides: CJC-1295 No-DAC at 5mg per vial and Ipamorelin at 5mg per vial, for a 1:1 mass ratio. CJC-1295 No-DAC is the 30-residue Modified GRF(1-29) sequence — a stabilized GHRH analogue that retains native GHRH-receptor agonism. Ipamorelin is a 5-residue selective ghrelin-receptor agonist with the sequence Aib-His-D-2-Nal-D-Phe-Lys. Each peptide also exists as a separate single-molecule product in our catalog with its own dedicated research guide. The combined formulation is supplied as a lyophilized blend for laboratory reconstitution.
CJC No-DAC + Ipamorelin is sold strictly for laboratory and research use. It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration.
Why these two peptides are combined
The growth-hormone axis has two principal entry points: the growth-hormone-releasing-hormone receptor (GHRHR) on somatotroph cells in the anterior pituitary, and the ghrelin / growth-hormone-secretagogue receptor (GHSR) on the same cell population. GHRHR agonism and GHSR agonism activate downstream GH-release pathways through different cellular mechanisms, and the published research literature consistently shows synergistic or at least additive effects when both pathways are engaged simultaneously rather than one in isolation. CJC-1295 No-DAC engages GHRHR; Ipamorelin engages GHSR. The 1:1 combined formulation packages this two-pathway approach into a single vial, supporting research designs that specifically aim to characterize the combined-pathway response without per-experiment manual mixing.
How CJC No-DAC + Ipamorelin quality is verified
Every batch of MHS Longevity CJC No-DAC + Ipamorelin is submitted to an independent third-party laboratory before release. The dual-component formulation requires per-component verification plus ratio confirmation:
- HPLC separates CJC-1295 No-DAC and Ipamorelin as distinct peaks. CJC-1295 No-DAC at 30 residues and Ipamorelin at 5 residues elute at substantially different retention times, which simplifies per-component quantification. Each component must meet the 99%+ per-component purity threshold within its own peak.
- Mass Spectrometry confirms both component identities. For Ipamorelin specifically, MS verifies that the non-standard amino acids (Aib, D-2-Nal, D-Phe) were correctly incorporated — an identity-check that HPLC alone may not always resolve cleanly.
- Component ratio verification confirms the 1:1 mass ratio of CJC-1295 No-DAC to Ipamorelin meets specification.
- Form confirmation verifies the CJC-1295 component is the No-DAC variant — not the DAC-modified form, which has a substantially different half-life profile. Mass spectrometry confirms the absence of the maleimidopropionyl modification that distinguishes the With-DAC version.
What the CJC No-DAC + Ipamorelin Certificate of Analysis shows
- Product name and composition. CJC-1295 No-DAC + Ipamorelin combined formulation, with per-component identification at 5mg each.
- Batch identifier. Unique ID linking certificate to vial.
- Test date. When the analysis was performed.
- Method. HPLC + MS for each component, with per-component retention and mass.
- Per-component purity. CJC-1295 No-DAC and Ipamorelin each at 99%+ within their respective peaks.
- Component ratio. 1:1 mass ratio meeting specification.
- CJC No-DAC form confirmation. MS confirms absence of the DAC (maleimidopropionyl) modification.
- Lab and signatures. The independent lab performing the analysis.
Storage and handling (research lab context)
Lyophilized CJC No-DAC + Ipamorelin should be stored at -20°C or below for extended stability. Once reconstituted in bacteriostatic water, the solution is typically held at 2–8°C and used within the documented stability window. Both peptides have similar in-solution stability profiles, so the combined formulation's stability window matches what either component would have individually. Single-use aliquoting after reconstitution helps preserve the 1:1 ratio across a study timeline. Repeated freeze–thaw cycles should be avoided. Standard aseptic technique applies during reconstitution.
Where to buy CJC no-DAC + Ipamorelin 5mg/5mg
The same eight questions apply whether you're buying CJC no-DAC + Ipamorelin 5mg/5mgfrom us or anywhere else. Vendors who can't answer any of them are worth a closer look.
Vendor evaluation checklist
1. Is the Certificate of Analysis public and downloadable?
A vendor unwilling to publish HPLC/MS results for the batch you're buying has nothing to verify their purity claim against.
2. Which testing method was used — HPLC, Mass Spectrometry, or both?
HPLC measures purity. Mass Spectrometry confirms the molecule's identity. Reputable batches go through both.
3. What's the verified purity percentage on the published COA?
Industry research standard is 99%+. Below that, you're paying for a compound diluted with synthesis byproducts.
4. Where does the product ship from?
US-based fulfillment generally means shorter handling times, customs-free delivery, and clearer return remedies.
5. Is the price published at a single list rate, or hidden behind tier locks?
Opaque pricing is a yellow flag. Transparent vendors quote the same number to every customer.
6. What's the free-shipping threshold, if any?
Compare the all-in cost (product + shipping + handling) — not just the headline price.
7. How is the product stored prior to shipment?
Lyophilized peptides degrade with temperature swings. Vendors should disclose temperature-controlled storage.
8. Is there a documented damage-claim and return policy?
Discreet shipping carries handling risk. A clear, written policy protects you when something goes wrong.
MHS LongevityThis site - Price
- $140
- Purity
- 99%+
- Testing
- HPLC + MS
- COA public
- US-based
- Free shipping
- $150+
- Last checked
- May 13, 2026
| Vendor | Price | Listed purity | Testing method | COA public | US-based | Free shipping | Last checked |
|---|---|---|---|---|---|---|---|
MHS LongevityThis site | $140 | 99%+ | HPLC + MS | $150+ | May 13, 2026 |
Competitor data sourced from each vendor's public product page on the date shown. Listed purity reflects each vendor's own published claim; Certificate of Analysis availability is verified at the URL above. Data may have changed since last check.